Bridging the Gap with Dr. Hall: Clinical Inertia and Its Impact on Health Disparities is organized by Pri-Med.
Release Date: 09/14/2022
Expiration Date: 09/14/2024
Description:
Clinical inertia is defined as a lack of treatment intensification in a patient not at evidence-based goals for care. Called by some “the enemy to therapeutic success,” clinical inertia essentially causes providers to “drag their feet” in adding additional medications or modalities used to attain treatment goals. Research has shown that communities of color, from several dynamics, suffer more from this phenomenon. We will look at the population outcomes related to diabetes, hypertension, and “watchful waiting” related to cancer diagnoses. Finally, we will look at proven approaches to lowering our tendency as providers to fall into this practice.
Learning Objectives:
• Define clinical inertia and look at its impact across racial/ethnic populations
• Summarize the health disparities in the US for cardiovascular diseases, diabetes management, and cancer treatment attributed to clinical inertia
• Review proven approaches to combating clinical inertia